Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium

In this study, we evaluate demographic information, cardiometabolic indices, symptoms and functioning in an antipsychotic free cohort at Clinical High Risk (CHR) for psychosis from the NAPLS Omega 3 fatty acid clinical trial.

Source: Schizophrenia Research - September 21, 2018 Category: Psychiatry Authors: Kristin S. Cadenhead, Amedeo Minichino, Skylar Kelsven, Jean Addington, Carrie Bearden, Tyrone D. Cannon, Barbara A. Cornblatt, Dan Mathalon, Thomas H. McGlashan, Diana O. Perkins, Larry J. Seidman, Ming Tsuang, Elaine F. Walker, Scott W. Woods, Jeff Yao, Source Type: research